Mice lacking β-arrestin-2 in melanocortin 4 receptor-expressing neurons show marked metabolic deficits

Misbah Rashid1, Lei Wang1, Zhenzhong Cui2

  • 1Molecular Signaling Section, Laboratory of Bioorganic Chemistry.

JCI Insight
|April 21, 2026
PubMed

Insights

Beta-arrestin-2 (barr2) mediates the appetite-suppressing effects of hypothalamic melanocortin 4 receptors (MC4Rs). This finding is crucial for developing new obesity drugs targeting MC4R signaling pathways.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Molecular Biology

Background:

  • Hypothalamic melanocortin 4 receptors (MC4Rs) are key regulators of energy homeostasis.
  • MC4R dysfunction is linked to monogenic obesity, highlighting the need to understand MC4R signaling.
  • MC4Rs interact with G proteins and beta-arrestin-2 (barr2), but barr2's role in MC4R signaling is unclear.

Purpose of the Study:

  • To investigate the functional role of beta-arrestin-2 (barr2) in MC4R-mediated regulation of food intake.
  • To determine if barr2 is required for the anorectic effects of MC4R agonists like setmelanotide.

Main Methods:

  • Utilized mutant mouse models to study MC4R signaling pathways.
  • Examined MC4R-mediated activation of barr2/ERK signaling in hypothalamic neurons.
  • Assessed the effect of setmelanotide in the presence or absence of barr2.

Main Results:

  • MC4R-mediated activation of barr2/ERK signaling in paraventricular nucleus neurons reduces food intake.
  • The appetite-suppressing effect of setmelanotide depends on the presence of barr2 in MC4R-expressing neurons.

Conclusions:

  • Beta-arrestin-2 (barr2) plays a critical role in mediating the anorectic effects of MC4R signaling.
  • MC4R agonists that enhance MC4R/barr2 interactions show potential as novel appetite-suppressing therapeutics for obesity.

Related Concept Videos